Quarterly Statement Of Cash Flows

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-433,507,000 JPY
-354,547,000 JPY
Interest paid
-1,061,000 JPY
-1,391,000 JPY
Income taxes paid
-2,850,000 JPY
-3,630,000 JPY
Net cash provided by (used in) operating activities
-435,804,000 JPY
-357,958,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-10,578,000 JPY
-20,169,000 JPY
Net cash provided by (used in) investing activities
-10,578,000 JPY
-24,104,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-80,004,000 JPY
-80,004,000 JPY
Proceeds from issuance of shares
388,258,000 JPY
JPY
Net cash provided by (used in) financing activities
308,339,000 JPY
-79,946,000 JPY
Net increase (decrease) in cash and cash equivalents
-138,043,000 JPY
-462,008,000 JPY
Cash and cash equivalents
2,531,683,000 JPY
2,669,727,000 JPY
2,773,493,000 JPY
3,235,502,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.